Intravenous perampanel as an alternative to the oral formulations in Japanese patients with epilepsy
Abstract Objective Perampanel is an oral anti‐seizure medication, which is approved in Japan for focal‐onset seizures, with/without focal to bilateral tonic–clonic seizures, as monotherapy/adjunctive therapy in patients aged 4 years and older. Treatment for generalized tonic–clonic seizures as adjun...
| Published in: | Epilepsia Open |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-12-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1002/epi4.12804 |
